5-Amino-1MQ vs NAD+: How They Work Together

The short version: NAD+ tops up the cell’s NAD+ pool directly, while 5-Amino-1MQ works upstream to stop that pool being drained. One is supply, the other is preservation — which is exactly why researchers look at them side by side.

First, why NAD+ matters

NAD+ (nicotinamide adenine dinucleotide) is one of the most important molecules in the cell. It’s a coenzyme involved in hundreds of reactions — converting nutrients into usable energy, supporting DNA-repair enzymes, and fuelling the sirtuin proteins that researchers study in the context of cellular ageing.

The catch studied across the literature is simple: NAD+ levels tend to fall over time, and the cell is constantly using it up. So research interest splits into two questions — how do you put NAD+ back in, and how do you stop it leaking out?

NAD+ — the “supply” side

Supplementing NAD+ (or its precursors such as NMN and NR in the wider literature) is the direct approach: you’re feeding the system the raw material it needs to rebuild its NAD+ pool. In research models this is the “top-up” lever — raise the available NAD+ so the enzymes that depend on it have more to work with.

On its own, though, supply has a ceiling. The cell also has machinery that removes NAD+ precursors from circulation — and that’s where the second compound comes in.

The hidden drain: an enzyme called NNMT

Nicotinamide is a key building block the cell recycles back into NAD+ through the “salvage pathway.” But an enzyme called NNMT (nicotinamide N-methyltransferase) can intercept that nicotinamide and methylate it — effectively tagging it for disposal instead of letting it be recycled into fresh NAD+.

When NNMT is overactive, more of your nicotinamide gets siphoned away. In research terms: you can keep pouring NAD+ precursors in, but a leaky bucket limits how much you actually keep.

5-Amino-1MQ — the “preservation” side

5-Amino-1MQ is studied as an NNMT inhibitor. By slowing that enzyme down, the idea explored in preclinical work is that more nicotinamide stays available to be recycled into NAD+, rather than being methylated and lost. In other words, it’s aimed at plugging the leak so the NAD+ the cell already has — and anything you supply — isn’t wasted as quickly.

Think of it like a sink: NAD+ is the tap topping the basin up, and 5-Amino-1MQ is the plug that keeps it from draining straight out.

Two sides of the same coin

	NAD+	5-Amino-1MQ
Role in research	Supplies / raises NAD+ directly	Inhibits NNMT to preserve NAD+ precursors
Mechanism	Adds raw material to the NAD+ pool	Reduces the “leak” that drains the pool
Analogy	The tap	The plug
Studied for	Energy metabolism, sirtuin activity, repair pathways	NNMT activity, metabolic models, NAD+ salvage

Why researchers look at them together

Supply and preservation are complementary, not competing. Topping up NAD+ while also limiting how fast it’s drained is a logical pairing in research design — you’re addressing both ends of the equation at once rather than fighting an uphill leak.

Where the evidence stops

• There’s no human trial of 5-Amino-1MQ. We found none on ClinicalTrials.gov and none in PubMed. The data is in cells and mice, like the 2018 obesity study below.
• Nobody we could find has tested the two together. The pairing is an idea from how they work, not a result.
• The NAD+ evidence is mostly in animals too. The 2018 review below covers the evidence that NAD+ falls with age and what restoring it did in old or diseased animals.

Quality is the part that actually matters

With any research compound, the molecule is only as good as its verification. Mislabelled identity or low purity makes results meaningless. That’s why we publish the independent Janoshik report for the compounds we have had tested, so you can read the identity and purity data before you order rather than take our word for it.

Where we hold an independent lab report for a product, it’s on our lab reports wall and the product page says so. Where we don’t, the product page says “No report held”.

If you’re sourcing these for research: 5-Amino-1MQ 10mg and NAD+ 500mg are both in stock. You can also browse the full catalogue and request a quote in seconds — no account, no checkout friction.

All products are supplied strictly for laboratory and research purposes only. Not for human or animal consumption.

Sources

• Neelakantan et al.: Selective and membrane-permeable small molecule inhibitors of nicotinamide N-methyltransferase reverse high fat diet-induced obesity in mice (Biochem Pharmacol, 2018)
• Kraus et al.: Nicotinamide N-methyltransferase knockdown protects against diet-induced obesity (Nature, 2014)
• Rajman, Chwalek and Sinclair: Therapeutic potential of NAD-boosting molecules: the in vivo evidence (Cell Metab, 2018)

Plain-English guides on Peptide Carl: NAD+ and 5-Amino-1MQ. Carl is the free education site we run.